In line with these findings, we confirmed that SKA1 overexpression was significantly associated with larger tumor size, higher TNM stage, serum AFP level and poor prognosis of HCC patients, suggesting that SKA1 may promote the growth and progression of cancer. This evidence concerns the gene SKA1 and hepatocellular carcinoma.